NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,495 | +0.9% | 535 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $53,987 | +11.8% | 535 | +1.9% | 0.01% | +14.3% |
Q1 2023 | $48,300 | -12.0% | 525 | -13.2% | 0.01% | -22.2% |
Q4 2022 | $54,886 | +19.3% | 605 | 0.0% | 0.01% | -10.0% |
Q3 2022 | $46,000 | -58.9% | 605 | -54.5% | 0.01% | -52.4% |
Q2 2022 | $112,000 | -17.0% | 1,329 | -13.3% | 0.02% | -16.0% |
Q1 2022 | $135,000 | +0.7% | 1,533 | 0.0% | 0.02% | -3.8% |
Q4 2021 | $134,000 | +6.3% | 1,533 | -0.7% | 0.03% | 0.0% |
Q3 2021 | $126,000 | -10.6% | 1,544 | 0.0% | 0.03% | -13.3% |
Q2 2021 | $141,000 | +14.6% | 1,544 | +7.3% | 0.03% | +11.1% |
Q1 2021 | $123,000 | -15.2% | 1,439 | -6.0% | 0.03% | -25.0% |
Q4 2020 | $145,000 | +4.3% | 1,531 | -4.3% | 0.04% | -14.3% |
Q3 2020 | $139,000 | -9.2% | 1,600 | -8.9% | 0.04% | -17.6% |
Q2 2020 | $153,000 | +2.0% | 1,757 | -3.5% | 0.05% | -16.4% |
Q1 2020 | $150,000 | -16.2% | 1,820 | -4.2% | 0.06% | -33.0% |
Q4 2019 | $179,000 | – | 1,899 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |